Finance
Results: 37837-37848 of 42191

Imlifidase demonstrated positive safety, tolerability, and early efficacy outcomes in 15-HMedIdeS-09 phase 2 trial in Guillain-Barré Syndrome (GBS)

The leading forum for public-private partnerships alongside COP returns for its 14th edition on 7-8 December at Conrad Dubai: World Climate Foundation







